Dear Colleague Letters
Updated March 27, 2024
2023
- Tuberculosis Trials Consortium launches new TB clinical trial
- CDC Releases “Reported Tuberculosis in the United States, 2022”
- CDC releases new TB resources for Uniting for Ukraine arrivals
- Rapid Testing for Fluoroquinolone (FQ) Resistance
- TB Drug Supply Interruptions and Shortages
- Updates to CDC Provisional Guidance for the Use of Pretomanid as part of a Regimen [Bedaquiline, Pretomanid, and Linezolid (BPaL)] to Treat Drug-Resistant Tuberculosis Disease
- A Letter from Dr. Rochelle P. Walensky, CDC Director, on World Tuberculosis Day
- CDC U.S. World TB Day 2023 Resources
2022
- Submission of 2023 TB Cases via 2020 RVCT
- CDC Releases “Reported Tuberculosis in the United States, 2021”
- TB Centers of Excellence for Training, Education, and Medical Consultation (TB COE)
- Venezuelan humanitarian relief program and TB testing
- Timing of TST or IGRA in relation to JYNNEOS vaccine
- Uniting for Ukraine – Drug Resistance Background and Recommendations
- Uniting for Ukraine Program
- A Letter from Dr. Rochelle P. Walensky, CDC Director, on World TB Day
- CDC announces Think. Test. Treat TB: a campaign to raise awareness of latent TB infection
- CDC Releases Interim Guidance on a Four-month TB Treatment Regimen
- CDC Releases New Provisional Guidance for the Use of Pretomanid as part of a Regimen [Bedaquiline, Pretomanid, and Linezolid (BPaL)] to Treat Drug-Resistant Tuberculosis Disease
- Journal of the American Medical Association: In-Person vs Electronic Directly Observed Therapy for Tuberculosis Treatment Adherence
- CDC U.S. World TB Day 2022 Resources
- Surveillance definitions for extensively drug resistant (XDR) and pre-XDR tuberculosis
2021
- CDC Releases “Reported Tuberculosis in the United States, 2020”
- Launch of the Tuberculosis Epidemiologic Studies Consortium (TBESC) III
- COVID mRNA vaccines, TST, and IGRA – Follow-up
- New England Journal of Medicine: TB Trial Identifies Shorter Four-Month Treatment Regimen
- Tuberculosis Trials Consortium Awards for the 2021-2030 Cycle
- CDC Releases 2020 Provisional U.S. Tuberculosis (TB) Data
- A Letter from Dr. Rochelle Walensky, CDC Director on World TB Day
- CDC U.S. World TB Day 2021: TB Elimination Champions Project Deadline Extended
- CDC U.S. World TB Day 2021 Resources
- TB Tests and mRNA COVID-19 Vaccines
2020
- CDC Releases “Reported Tuberculosis in the United States, 2019”
- Landmark TB Trial Identifies Shorter-Course Treatment Regimen
- Update on Rifamycin Issues – September 11, 2020
- Print Copies Available for Order- UPDATED Latent Tuberculosis Infection: A Guide for Primary Health Care Providers
- Rifampin Availability and Discontinuation of Sanofi-Aventis Rifampin Products – August 18, 2020
- Maintaining Essential Components of TB Control Programs – July 30, 2020
- Reported Rifapentine Impurity – June 18, 2020
- A Letter from Dr. Robert Redfield, CDC Director on World TB Day
PDF Version - CDC World TB Day Resources – March 24, 2020
- 2020 TB Elimination Champions
- CDC and the National Tuberculosis Controllers Association Release New Guidelines for Treatment of Latent TB Infection
2019
- NEW Drug-Resistant TB Treatment Guidelines and CDC Antibiotic Resistance Threats Report
- CDC Releases “Reported Tuberculosis in the United States, 2018
- Nationwide Shortage of Tuberculin Skin Test Antigens: CDC Recommendations for Patient Care and Public Health Practice – June 7, 2019
- CDC and the National Tuberculosis Controllers Association Releases Updated Recommendations for Tuberculosis Screening, Testing and Treatment for Health Care Personnel – May 16, 2019
- World TB Day – March 24, 2019